NOVO NORDISK A/S |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 883.2 DKK | +0.07% |
|
+1.16% | +26.51% |
| May. 10 | Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll shows | RE |
| May. 10 | India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NOVO NORDISK A/S | Other Pharmaceuticals | +0.07% | +1.16% | +26.51% | +54.70% | +447.98% | 568B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- NOVO B Stock
- Charts Novo Nordisk A/S
- Comparison Chart
